Indonesian Journal of Perinatology
Vol. 1 No. 1 (2020): Available Online: 1 December 2020

Management of polyhydramnios pregnancy without risk factors: a case report

I Nyoman Hariyasa Sanjaya (Fetomaternal Division, Departement of Obstetrics and Gynecology, Faculty of Medicine, Universitas Udayana/Sanglah General Hospital, Bali, Indonesia)
Ryan Saktika Mulyana (Fetomaternal Division, Departement of Obstetrics and Gynecology, Faculty of Medicine, Universitas Udayana/Sanglah General Hospital, Bali, Indonesia)
Evert Solomon Pangkahila (Fetomaternal Division, Departement of Obstetrics and Gynecology, Faculty of Medicine, Universitas Udayana/Sanglah General Hospital, Bali, Indonesia)
Denni Prasetyo (Departement of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Udayana/Sanglah General Hospital, Bali, Indonesia)



Article Info

Publish Date
26 Aug 2020

Abstract

Introduction: Polyhydramnios is a condition in which the amount of amniotic fluid increases more than 2 litres. The causes of polyhydramnios are multifactorial, and most are idiopathic. Here we report challenging management of polyhydramnios case without apparent risk factors. Case: A 30-year-old woman G2P1001, 27-28 weeks of gestational age referred due to our tertiary health care center due to polyhydramnios. The patient chief complaint was progressively enlarged abdomen since a month ago. Her previous pregnancy, medical history and family history were unremarkable. The obstetric examination reflects the size of uterus equivalent to 36 weeks of gestational age. The fetomaternal ultrasound reveals a life, single fetus with normal heart rate and fetal movement, estimated fetal weight about 1057 grams, placenta corpus posterior grade I, Maximum Vertical Pocket 22.83 cm, no major congenital abnormalities were visible and bladder appears filled. Laboratory tests revealed blood glucose levels 90 mg/dl, Hb-A1c 5.2%, Ureum 27.30 mg/dl, Creatinine 3.39 mg/dl, and numerous leukocytes on urine sediment. Amnioreduction and fetal pulmonary maturation were conducted by Dexamethason protocol. Amnioreduction yield 1500 ml of clear, yellowish amniotic fluid. Regarding abnormality in renal function, diagnosis of Acute on Chronic Kidney Disease (ACKD were established by Internal medicine department, and the patients were given a series of ceftriaxone injection. The patient was planned for indomethacin therapy; however, Indomethacin was not available in Bali. Conclusion: Careful search for causes both from the maternal factor and fetal abnormalities can help to determine the prognosis of pregnancy. Ideally, amnioreduction, coupled with indomethacin therapy, are needed to reduce amniotic fluid, and serial monitoring of the amniotic fluid volume is required to prevent preterm labor.

Copyrights © 2020






Journal Info

Abbrev

InaJPerinatol

Publisher

Subject

Health Professions Medicine & Pharmacology Nursing

Description

peer-reviewed journal aiming to communicate high-quality research articles, reviews, and general articles in the field. InaJPerinatol publishes articles that encompass basic research/clinical studies related to the cardiovascular and thorax field. The Journal aims to bridge and integrate the ...